We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPHI
201
DELISTED
INPHI CORPORATION
IPHI
$2.87M 0.04%
83,573
+15,000
+22% +$603K
TSM icon
202
TSMC
TSM
$2.09T
$2.82M 0.04%
80,768
+74,177
+1,125% +$2.56M
PANW icon
203
Palo Alto Networks
PANW
$264B
$2.77M 0.04%
124,200
– –
HDB icon
204
HDFC Bank
HDB
$119B
$2.56M 0.03%
117,612
-15,112
-11% -$316K
NVDQ
205
DELISTED
Novadaq Technologies Inc.
NVDQ
$2.22M 0.03%
189,611
-150,000
-44% -$1.19M
NMFC icon
206
New Mountain Finance
NMFC
$646M
$2.18M 0.03%
150,000
-17,250
-10% -$252K
MCO icon
207
Moody's
MCO
$81.7B
$2.09M 0.03%
17,212
– –
TSLA icon
208
Tesla
TSLA
$1.24T
$1.99M 0.03%
+82,500
New +$1.82M
MIXT
209
DELISTED
MIX TELEMATICS LIMITED
MIXT
$1.94M 0.03%
245,454
-70,096
-22% -$466K
TWTR
210
DELISTED
Twitter, Inc.
TWTR
$1.9M 0.03%
106,125
-109,975
-51% -$1.87M
IMAX icon
211
IMAX
IMAX
$2.38B
$1.88M 0.03%
+85,412
New +$2.4M
POWI icon
212
Power Integrations
POWI
$3.54B
$1.71M 0.02%
46,858
-368,848
-89% -$12.2M
MTLS
213
Materialise
MTLS
$379M
$1.68M 0.02%
141,662
-6,400
-4% -$74.4K
BSFT
214
DELISTED
BroadSoft, Inc.
BSFT
$1.61M 0.02%
37,396
-18,000
-32% -$707K
RARX
215
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.41M 0.02%
+75,000
New +$1.69M
PTGX icon
216
Protagonist Therapeutics
PTGX
$8.75B
$1.13M 0.02%
100,000
+75,000
+300% +$802K
RXDX
217
DELISTED
Ignyta, Inc.
RXDX
$1.03M 0.01%
+100,000
New +$812K
CFG icon
218
Citizens Financial Group
CFG
$30.4B
$1.01M 0.01%
28,236
+10,024
+55% +$355K
ONCE
219
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$896K 0.01%
+15,000
New +$838K
BKD icon
220
Brookdale Senior Living
BKD
$3.62B
$883K 0.01%
60,000
– –
MULE
221
DELISTED
MuleSoft, Inc.
MULE
$743K 0.01%
29,847
+14,847
+99% +$359K
ANAB icon
222
AnaptysBio
ANAB
$1.6B
$718K 0.01%
30,000
+5,000
+20% +$126K
NGNE icon
223
Neurogene
NGNE
$696M
$704K 0.01%
2,500
+500
+25% +$143K
VIVO
224
DELISTED
Meridian Bioscience Inc
VIVO
$700K 0.01%
44,600
– –
AGU
225
DELISTED
Agrium
AGU
$633K 0.01%
7,000
+2,000
+40% +$185K
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.